Influenza A virus changes shape to evade immune responses

Influenza A virus particles strategically adapt their shape-to become either spheres or larger filaments-to favor their ability to...

Discovery of special dendritic cells sheds light on food allergy prevention

The immune system must be able to quickly attack invaders like viruses, while also ignoring harmless stimuli, or...

New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is...

Asthma and allergy rates higher among First Nations people in Australia

Researchers at The University of Queensland have found First Nations people are twice as likely to present at...

Research links high pollen exposure to increased death rates in older adults

As climate change intensifies pollen seasons across the country, new research from the University of Michigan reveals a...

New human antibody shows promise for Ebola virus treatment

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human...

Omalizumab outperforms oral immunotherapy in treating multi-food allergy

A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than...

T cells play key role in protecting children from severe dengue

Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a...

New CT-based score helps predict need for repeat sinus surgery

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery...

Gut bacteria could one day serve as microscopic in-house pharmacists

Hundreds of different species of microbes live, laugh, and love in your gut. In the future, one of...

New antibiotic offers hope for more effective Lyme disease treatment

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then...

Scientists uncover why Lyme disease symptoms may linger after treatment

Symptoms that persist long after Lyme disease is treated are not uncommon - a 2022 study found that 14%...

Feeding infants diverse foods early may cut allergy risk, study reveals

New research reveals that feeding infants a variety of foods in their first year can help prevent allergies...

Long-acting HIV injections show success in patients with struggles to take daily pills

UCSF researchers are the first to demonstrate that the approach works for the patients who need it the...

Material from nasal lavage provides a basis for assessing COPD

Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the...

New study reveals hidden spread of C. diff in intensive care units

One of the most common health care-associated infections spreads within intensive care units (ICUs) more than three times...

Understanding FDA’s complaint reporting systems

If you have a complaint about a product regulated by the U.S. Food and Drug Administration (FDA), the...

Machine learning algorithm decodes immune system’s hidden data for disease detection

Your immune system harbors a lifetime's worth of information about threats it's encountered - a biological Rolodex of...

Study: Trust in personal doctors divided along political lines

Democrats are more likely to trust their personal doctors and follow their doctors' advice than Republicans, new research...

NIH clinical trial examines investigational therapy for dengue

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to...

Influenza A virus changes shape to evade immune responses

Influenza A virus particles strategically adapt their shape-to become either spheres or larger filaments-to favor their ability to infect cells depending on environmental conditions, according to a new study from National Institutes of Health (NIH) scientists. This previously unrecognized response could help explain how influenza A and other viruses persist in populations, evade immune responses, and acquire adaptive mutations, the researchers explain in a new study published in Nature Microbiology.

The study, led by intramural researchers at NIH's National Institute of Allergy and Infectious Diseases (NIAID), was designed to determine why many influenza A virus particles exist as filaments. The filament shape requires more energy to form than a sphere, they state, and its abundance has been previously unexplained. To find the answer, they developed a way to observe and measure real-time influenza A virus structure during formation.

The researchers found: 

  • Influenza A viruses rapidly adjust their shape when placed in conditions that reduce infection efficiency, such as the presence of antiviral antibodies or host incompatibility.
  • A virus' shape is dynamic and impacted by its environment, rather than being fixed by strain, as commonly believed. 
  • The study assessed 16 different virus-cell combinations that resulted in predictable shape trends.

Prior experiments by the research team showed that influenza A virus filaments can resist inactivation by antibodies, and the team is working to understand exactly how antibodies influence shape and infection efficiency. They also anticipate learning how viral mutations affect the shape of the virus. Many other viruses-such as measles, Ebola, Nipah, Hendra and respiratory syncytial virus-also incorporate a mixed-shape infection strategy, the researchers note.

Source:

NIH/National Institute of Allergy and Infectious Diseases

Journal reference:

Partlow, E. A., et al. (2025). Influenza A virus rapidly adapts particle shape to environmental pressures. Nature Microbiology. doi.org/10.1038/s41564-025-01925-9.


Source: http://www.news-medical.net/news/20250210/Influenza-A-virus-changes-shape-to-evade-immune-responses.aspx

Inline Feedbacks
View all comments
guest